Protocol for the isotoxic intensity modulated radiotherapy in stage III non-small cell lung cancer : a feasibility study. The majority of stage III patients with non-small cell lung cancer are unsuitable for concurrent chemoradiotherapy, the non-surgical gold standard of care.